Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Pemetrexed alters inflammatory profile in EA.hy 926 cells grown under low-folate conditions.


ABSTRACT: Pemetrexed is an antifolate drug used in the treatment of lung cancer. EA.hy 926 cells grown under low (Lo) and normal (Hi) folate conditions were treated with PMX. Microarray analysis was used to examine changes in gene expression due to PMX treatment. Hi and Lo cells were grown to confluence and maintained in fresh medium for 24 hours prior to treatment with 0.5uM PMX for 48 hours.

ORGANISM(S): Homo sapiens

SUBMITTER: Andrea Hammons 

PROVIDER: E-GEOD-31986 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions.

Hammons Andrea L AL   Summers Carolyn M CM   Jochems Jeanine J   Arora Jasbir S JS   Zhang Suhong S   Blair Ian A IA   Whitehead Alexander S AS  

European journal of pharmacology 20120905 1-3


Elevated homocysteine is a risk marker for several major human pathologies. Emerging evidence suggests that perturbations of folate/homocysteine metabolism can directly modify production of inflammatory mediators. Pemetrexed acts by inhibiting thymidylate synthetase (TYMS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT). EA.hy 926 cells grown under low ("Lo") and high ("Hi") folate conditions were treated with pemetrexed. The concentrations of several in  ...[more]

Similar Datasets

2012-09-30 | E-GEOD-32008 | biostudies-arrayexpress
2012-10-03 | GSE31986 | GEO
2012-09-30 | GSE32008 | GEO
2014-10-31 | E-GEOD-61513 | biostudies-arrayexpress
2019-05-27 | E-MTAB-7148 | biostudies-arrayexpress
2010-06-08 | E-GEOD-13743 | biostudies-arrayexpress
2018-05-25 | GSE114884 | GEO
2011-10-31 | E-GEOD-31551 | biostudies-arrayexpress
2017-05-22 | E-MTAB-4987 | biostudies-arrayexpress
2021-08-20 | GSE118826 | GEO